5th Annual
Neuroscience Drug Development Europe Congress22 - 23 May 2024 | Basel, Switzerland
A thorough, 2-day event addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies for neurodegenerative diseases
Benefits to attending the 5th Annual Neuroscience Drug Development Europe Congress include…
- Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies
- Discuss the pioneering innovations in stem cell technologies, with the latest updates on iPS cells for disease modelling and drug discovery
- Establish in-depth knowledge of cutting-edge recent advances in gene therapy for CNS drug discovery and current opportunities for digital biomarkers in neuroscience
- Unparalleled networking opportunities with leading researchers, fostering a solution-oriented environment
This Year's Agenda at a Glance
Day One
Therapeutic Strategies, Enabling Technologies & Biomarker Development
- Advancements and emerging trends in the application of technology in developing neurological treatments
- Neuroscience biomarker development
- Translational approaches for drug discovery
- Opportunities and challenges of designing and implementing targeted diagnostics and therapeutics
- Diagnostic tool development
- AI, digital and Imaging strategies for Biomarker development
Day Two
Drug Discovery for Neurodegenerative Diseases
- Target identification and validation approaches
- Neurodegenerative and Neuroinflammation/Immunology models for robust drug discovery
- Stem cell technology to fuel drug discovery
- iPS cells for disease modelling and drug discovery
- Blood brain barrier in CNS drug discovery
- Assay Development & Screening
- In vitro and in vivo disease modelling
- The role of informatics in CNS drug discovery